BenQ Medical Technology Corporation

Total Valuation

BenQ Medical Technology Corporation carries a market capitalization of 1.70B, placing it among publicly traded companies globally. Its enterprise value stands at 3.77B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

BenQ Medical Technology Corporation currently has 44.57M shares outstanding.

Valuation Ratios

BenQ Medical Technology Corporation trades at a trailing price-to-earnings ratio of 21.29. The price-to-sales ratio is 0.35, and the price-to-book ratio stands at 2.30.

Enterprise Valuation

On an enterprise value basis, BenQ Medical Technology Corporation trades at an EV/EBITDA multiple of 10.72 and an EV/FCF ratio of 8.17. The EV/Sales ratio of 0.74 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 10.72 provides insight into valuation relative to core operating earnings.

Financial Position

BenQ Medical Technology Corporation maintains a current ratio of 1.58, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 92.31, indicating elevated leverage, while an interest coverage ratio of 8.87 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

BenQ Medical Technology Corporation posts a return on equity of 10.93 and a return on invested capital of 6.28.

Taxes

Over the trailing twelve months, BenQ Medical Technology Corporation has paid 98.01M in income taxes, reflecting an effective tax rate of 30.78.

Stock Price Statistics

BenQ Medical Technology Corporation's stock has declined approximately -5.80247% over the past 52 weeks. The 50-day moving average sits at 38.11, while the 200-day moving average is 42.49.

Income Statement

Over the trailing twelve months, BenQ Medical Technology Corporation generated 5.10B in revenue and converted that into 84.96M in net income, yielding earnings per share of 4.95. EBITDA reached 351.33M, while operating income came in at 351.33M.

Balance Sheet

BenQ Medical Technology Corporation holds 1.07B in cash and equivalents against 1.96B in total debt, resulting in a net debt position of 791.32M. Total book value stands at 784.75M, with working capital of 1.15B providing operational flexibility.

Cash Flow

BenQ Medical Technology Corporation produced 302.71M in operating cash flow over the past twelve months. After subtracting -131.25M in capital expenditures, free cash flow totaled 171.46M - equivalent to 3.86 per share.

Margins

BenQ Medical Technology Corporation operates with a gross margin of 31.15, reflecting its pricing power and cost economics. The operating margin of 6.89 and net profit margin of 1.67 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

BenQ Medical Technology Corporation's most recent stock split took place on October 6, 2008 with a 5:4 split ratio.

Scores

BenQ Medical Technology Corporation posts an Altman Z-Score of 2.02, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.